Announcements Trials
Browse Landscape

Status

Completed 45Recruiting 20Unknown 14Terminated 8Active not recruiting 6Not yet recruiting 5Withdrawn 4Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Neoplasms 33Breast Neoplasms 32Lung Neoplasms 17Colorectal Neoplasms 16Prostatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Hematologic Neoplasms 12Stomach Neoplasms 11Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Diabetes Mellitus 9Melanoma 7Disease 7Colonic Neoplasms 7Pulmonary Disease, Chronic Obstructive 6Cardiovascular Diseases 6Barrett Esophagus 6Urinary Bladder Neoplasms 5Rectal Neoplasms 5Liver Neoplasms 5Leukemia, Myeloid, Acute 5Fatigue 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pheochromocytoma 4Myasthenia Gravis 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma 4Lymphatic Metastasis 4Leiomyoma 4

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Myeloproliferative Disorders × Clear all
NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡